DARIOHEALTH CORP

DRIONASDAQ

🏆 #3137 by market capEarnings Nov 12US Equity

$402.02▲ $28.26 (+7.03%)

Simulated price

1h—

24h▲ 7.0%

7d—

14d—

30d—

1y—

🏦Market Cap

$75M

Small Cap

📈Revenue Growth (YoY)

-24.4%

Declining

📊Gross Margin

56.5%

Healthy

💵FCF Margin

—

⚖️P/S Ratio

3.4x

Fair

Otter Score

Fair

No chart data available for DRIO.

Trading Snapshot

Day Range: $398.36 – $409.80
52-Week Range: $5.84 – $17.74
Volume: $4.41B
Avg Volume: $4.98B
Shares Outstanding: 9.8M
Next Earnings: Sep 19, 2026

Fundamentals Snapshot

Annual Revenue: $22M
Last Q Revenue: $5M
P/E Ratio: —
P/S Ratio: 3.4x
EPS (TTM): $-10.96
Dividend Yield: —

Why Investors Own DRIO

✓High-growth profile — revenue up +25.5% YoY with expanding US Equity exposure.
✓Healthy economics — 78% gross margin and 13% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$22M▲ +31.6% YoY

Gross Margin (TTM)

78.1%▲ +3.8% YoY

Operating Income (TTM)

$7M▲ +31.6% YoY

Free Cash Flow (TTM)

$3M▲ +31.6% YoY

About DARIOHEALTH CORP

DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.

🦦